Suppr超能文献

[不同结核菌素制剂等效性的研究]

[Investigations on the equivalent of different tuberculin preparations].

作者信息

Mydlak G, Götz J

出版信息

Z Erkr Atmungsorgane. 1982;158(1-2):224-32.

PMID:7072269
Abstract

Report on the comparison of the effectiveness of seven tuberculin preparations from 6 countries to RT 23. In 2 field trials performed among tuberculous patients with confirmed excretion of tubercle bacilli significant differences have been found among the preparations when their effectiveness and specificity was determined expressed in terms of the rate of negative (0-5 mm) reactions and the size of reaction and its range of variation. Only three of the seven preparations were equivalent to RT 23, one of them was even superior to it; another of the equivalent preparations originated from the stock substance of RT 23. However, one among the deviating preparations originated from RT 23, too, having a threefold higher rate of negative tuberculin reactions. Investigations in the USA with tuberculin preparations from this country done in time parallel to those reported here, had a similar result and the same conclusions. There are set limits to the comparison of testing results with tuberculins of different production. Thus, the comparison of incidence and prevalence of tuberculous infection obtained with different tuberculins must be met only with caution.

摘要

关于来自6个国家的七种结核菌素制剂与RT 23有效性比较的报告。在两项针对确诊有结核杆菌排出的结核病患者进行的现场试验中,当根据阴性(0 - 5毫米)反应率、反应大小及其变化范围来确定制剂的有效性和特异性时,发现不同制剂之间存在显著差异。七种制剂中只有三种与RT 23相当,其中一种甚至优于RT 23;另一种等效制剂源自RT 23的原料。然而,在偏离的制剂中有一种也源自RT 23,其阴性结核菌素反应率高三倍。美国同期对该国结核菌素制剂进行的调查与本文报道的调查结果相似,得出了相同的结论。不同生产厂家的结核菌素检测结果比较存在一定限制。因此,对于不同结核菌素获得的结核感染发病率和患病率的比较必须谨慎对待。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验